Back to search

Article

Macrophages target PVR/CD155 on colorectal cancer cells via REVERBα

2026-01-29

Abstract excerpt

<h4>Background&Aims</h4> Patients with microsatellite-instable (MSI) colorectal cancer (CRC) benefit from immune checkpoint therapy. For patients with microsatellite-stable (MSS) non-MSI tumors targeting alternative immune checkpoints, such as the Poliovirus receptor (PVR/CD155), may extend response to checkpoint inhibitors and thereby improve outcomes. The drugable transcription factor REVERBα ( NR1D1 ) is a m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5f8757bf-6ed9-5318-a45d-b408c4de406c
DOI
10.64898/2026.01.29.702476
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Macrophages target PVR/CD155 on colorectal cancer cells via REVERBαDOI 10.64898/2026.01.29.702476
Select a neighboring publication to make it the new centre.